expect more with siegfried as your preferred partner siegfried at a glance
TRANSCRIPT
Expect more with Siegfried as your preferred partner
Siegfried at a glance
• Commitment of some 850 employees
• First choice in compliance, responsiveness and reliability
• Over 130 years of continuity, global presence
• Process Development experience from over 1,600 substances, extensive services
Overview
3
Overview
Our Vision
Expect more with Siegfried as your preferred partner
Bringing together our long-standing pharma and chemical heritage, we offer as an integrated partner benefit to our customers with more synergy, expertise and value.
Explore more about how our broad range of custom development services, drug substance & drug product manufacturing capabilities, together with our existing product portfolio may help you achieve greater value.
4
Overview Locations
5
Overview
Past do Present
1873 Pharmacist Samuel Benoni Siegfried founds a company with 12 employees as a supplier to
pharmacies1904 Conversion into a joint stock
corporation 1937 Founding of Ganes Chemical
Works, Inc. (NJ, USA)1973 Quotation on the Swiss Stock
Exchange (SWX) in Basel1991 Focus on development and custom manufacturing2001 Building of two core divisions:
Siegfried and Sidroga
6
Overview
Past to Present
2001 Integration of Ganes into the Siegfried Group = Siegfried (USA) Inc.
2005 Acquisition of Penick Corporation in New Jersey, USA
2007 Launch of a new pharmaceutical production facility in Malta Sale of the Sidroga Division Sale of the biotech activities
2008 Sale of the pharmaceutical production site Zofingen
2010 Definition of new strategy «Transform»Implementation of a new function- based organisation. New investors and capital increase. Sale of Munich, Germany subsidiary (Pulmojet project) to Sanofi-Aventis.
7
Strategy Position
8
Drug Substances
Custom synthesis of APIs and intermediates, as well as production of standard substances, particularly controlles substances for analgesics and narcotics.
Drug Products
Process development and production of complex drug products and finished dosage forms.
Products & Services
Two Strong Business Areas
Business Area
Products & Services
Gilbert AchermannChairman
Felix Meyer
Reto Garzetti Thomas Villiger.Andreas Casutt
Reto Garzetti
ManagementBoard of Directors
Arnoud MiddelHead Human Resources
Peter GehlerHead Corporate CenterSecretary to the Board of Directors
Rudolf HankoChief Executive Officer
Michael HüslerChief Financial Officer
Walter KittlHead Technical Operations
Marianne SpäneHead Business Development & Sales
Wolfgang Wienand.Chief Scientific Officer, Head of Strategy and M & A
ManagementExecutive Committee
René ImwinkelriedHead Research & Development
11
Human Resources
Vision
• Socially responsible employer • Motivated and talented personnel • Mutual respect
• Personal responsibility• Focusing on results
Expect more with Siegfried as your preferred partner
Thank you for your attention